BETA-CAROTENE INHIBITS THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN

被引:208
|
作者
JIALAL, I
NORKUS, EP
CRISTOL, L
GRUNDY, SM
机构
[1] UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235
[2] UNIV TEXAS,SW MED CTR,DEPT CLIN NUTR,DALLAS,TX 75235
[3] NEW YORK MED COLL,BRONX,NY
[4] OUR LADY MERCY MED CTR,BRONX,NY
关键词
ANTIOXIDANT; LIPOPROTEIN; BETA-CAROTENE; ATHEROSCLEROSIS; (HUMAN MACROPHAGE);
D O I
10.1016/0005-2760(91)90164-D
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several lines of evidence indicate that oxidized LDL (Ox-LDL) may promote atherogenesis. Hence, the role of antioxidants in the prevention of LDL oxidation needs to be determined. Beta-Carotene, in addition to being an efficient quencher of singlet oxygen, can also function as a radical-trapping antioxidant. Since previous studies have failed to show that beta-carotene inhibits LDL oxidation, we re-examined its effect on the oxidative modification of LDL. For these studies, LDL was oxidized in both a cell-free (2.5-mu-M Cu2+ in PBS) and a cellular system (human monocyte macrophages in Ham's F-10 medium). Beta-Carotene inhibited the oxidative modification of LDL in both systems as evidenced by a decrease in the lipid peroxide content (thiobarbituric-acid-reacting substances activity), the negative charge of LDL (electrophoretic mobility) and the formation of conjugated dienes. By inhibiting LDL oxidation, beta-carotene substantially decreased its degradation by macrophages. Beta-Carotene (2-mu-M) was more potent than alpha-tocopherol (40-mu-M) in inhibiting LDL oxidation. Thus, beta-carotene, like ascorbate and alpha-tocopherol, inhibits LDL oxidation and might have an important role in the prevention of atherosclerosis.
引用
下载
收藏
页码:134 / 138
页数:5
相关论文
共 50 条
  • [21] THYROXINE INHIBITS OXIDATIVE MODIFICATION OF HUMAN LOW-DENSITY LIPOPROTEIN BETA-LIPOPROTEIN
    KAMANNA, VS
    NEWMAN, HAI
    FELLER, DR
    WITIAK, DT
    FASEB JOURNAL, 1988, 2 (05): : A1218 - A1218
  • [22] THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN BY HUMAN-LYMPHOCYTES
    LAMB, DJ
    WILKINS, GM
    LEAKE, DS
    ATHEROSCLEROSIS, 1992, 92 (2-3) : 187 - 192
  • [23] EFFECT OF ACETAMINOPHEN ON OXIDATIVE MODIFICATION OF HUMAN LOW-DENSITY-LIPOPROTEIN
    LANNINGHAM, L
    CHANCE, DS
    CHEN, C
    LOO, G
    FASEB JOURNAL, 1994, 8 (04): : A449 - A449
  • [24] OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN BY DIESEL EXHAUST PARTICLES
    IKEDA, M
    SHITASHIGE, M
    YAMASAKI, H
    SAGAI, M
    TOMITA, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1995, 18 (06) : 866 - 871
  • [25] THIOL-MEDIATED OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN
    PARTHASARATHY, S
    STEINBERG, D
    ARTERIOSCLEROSIS, 1986, 6 (05): : A542 - A542
  • [26] Ibuprofen inhibits oxidative modification of low density lipoprotein
    ZapolskaDownar, D
    ZapolskiDownar, A
    Bukowska, H
    Modrzejewski, A
    Naruszewicz, M
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 209 - 209
  • [27] Dilazep inhibits the oxidative modification of low density lipoprotein
    Kawasaki, S
    Taniguchi, T
    Takahashi, A
    Shimizu, H
    Yoshida, H
    Oda, A
    Ishikawa, Y
    Yokoyama, M
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 204 - 204
  • [28] NO EFFECT OF BETA-CAROTENE SUPPLEMENTATION ON THE SUSCEPTIBILITY OF LOW-DENSITY-LIPOPROTEIN TO IN-VITRO OXIDATION AMONG HYPERCHOLESTEROLEMIC, POSTMENOPAUSAL WOMEN
    NENSETER, MS
    VOLDEN, V
    BERG, T
    DREVON, CA
    OSE, L
    TONSTAD, S
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1995, 55 (06): : 477 - 485
  • [29] CELLULAR OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN DOES NOT REQUIRE LIPOXYGENASES
    SPARROW, CP
    OLSZEWSKI, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (01) : 128 - 131
  • [30] INHIBITION OF OXIDATIVE MODIFICATION OF HUMAN LOW-DENSITY-LIPOPROTEIN BY DARK BEER
    WHITEHEAD, R
    LANNINGHAM, L
    LOO, G
    FASEB JOURNAL, 1995, 9 (04): : A893 - A893